
Jorge Monge Urrea MD
Hematologic Oncology
Assistant Professor of Medicine, University of Colorado Anschutz Medical Campus
Join to view full profile
Uchealth Hematology Clinic Anschutz Medical Campus 1665 Aurora Court Anschutz Cancer Pavilion3rd FloorAurora, CO 80045
Phone+1 720-848-6400
Fax+1 720-848-1786
Dr. Monge Urrea is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jorge Monge, MD, is a hematologist in Aurora, CO. He graduated from Universidad Anahuac in 2011 and completed his residency in Internal Medicine at Jackson Memorial Hospital, University of Miami, and a fellowship in Hematology & Oncology at NewYork-Presbyterian Hospital, Weill Cornell Medicine. Currently, he is an Assistant Professor at the University of Colorado Anschutz.
Education & Training
Universidad Anahuac School of MedicineClass of 2011
Certifications & Licensure
CO State Medical License 2024 - 2027
MT State Medical License 2025 - 2027
WY State Medical License 2025 - 2027
CT State Medical License 2024 - 2024
NY State Medical License 2017 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Scott Wadler Memorial Fellow Clinical Research Award Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, 2020
- 5 time recipient of the Academic Excellence Award Universidad Anahuac, 2004-2008
- Outstanding Performance Award CENEVAL
Clinical Trials
- Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients Start of enrollment: 2021 Dec 29
- A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) Start of enrollment: 2023 Oct 16
- Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma Start of enrollment: 2012 Apr 19
Publications & Presentations
PubMed
- Abnormal serum immunofixation patterns are common after BCMA CAR-T in multiple myeloma and are preceded by immune events.Caitlin Unkenholz, Esther Ortega-Vida, Jorge Monge, Christian A Gordillo, Juan Esteban Velez-Hernandez
Blood Neoplasia. 2026-11-01 - 7 citationsReal-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.Gaurav Varma, Lindsay Fogel, Beth Gordon, Mateo Mejia Saldarriaga, Jaeil Ahn
Leukemia & Lymphoma. 2025-05-01 - 2 citationsExploring health disparities in diagnosing multiple myeloma.Nima Ghalehsari, Sofia Zahid, Olivia Main, Soeb Usta, John Patresan
Expert Review of Hematology. 2024-10-01
Journal Articles
- Predicting multiple myeloma disease activity by analyzing natural calcium isotopic compositionGordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Leukemia, 1/1/2014
- Sudden cardiac arrest at the finish line: in coronary ectopia, the cause of ischemia is from intramural course, not ostial locationJoggerst S, Monge J, Uribe C, Sherron S, Angelini P, Tex Heart Inst J, 1/1/2014
- Staging and prognostication of multiple myelomaFonseca R, Monge J, Dimopoulos MA, Expert Rev Hematol, 1/1/2014
Books/Book Chapters
Abstracts/Posters
- Harnessing the Epichaperome As a Therapeutic Approach in Multiple MyelomaJorge Monge, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Cyclophosphamide, bortezomib, and dexamethasone (CYBORD) treatment for relapsed/refractory multiple myelomaMonge J, Kortum KM, Stewart AK, Bergsagel PL, Mikhael J, Reeder CB, Mayo A, Fonseca R, J Clin Oncol, 1/1/2014
- Calcium Isotopic Composition and Its Association With Multiple Myeloma Disease ActivityGordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Blood, 1/1/2013
Press Mentions
PublicationsMarch 14th, 2025
Professional Memberships
- Member
- Member
- International Myeloma SocietyMember
- International Myeloma Working GroupMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: